Neonatal hypomagnesemia
ICD-10 P71.2 is a billable code used to indicate a diagnosis of neonatal hypomagnesemia.
Neonatal hypomagnesemia is characterized by low serum magnesium levels in newborns, which can lead to various clinical manifestations. This condition is often transitory and may arise due to inadequate maternal magnesium intake, prematurity, or certain medications administered during pregnancy. Hypomagnesemia can result in neuromuscular irritability, seizures, and cardiac arrhythmias. It is crucial to monitor magnesium levels in high-risk infants, particularly those in the neonatal intensive care unit (NICU) or those with low birth weight. Treatment typically involves magnesium supplementation, either orally or intravenously, depending on the severity of the deficiency. Understanding the interplay between magnesium and calcium metabolism is essential, as hypomagnesemia can also contribute to hypocalcemia, further complicating the clinical picture. Early identification and management are vital to prevent long-term neurological deficits and ensure optimal outcomes for affected newborns.
Detailed records of serum magnesium levels, clinical symptoms, and treatment plans.
Infants in the NICU presenting with seizures or neuromuscular irritability.
Consideration of maternal health and dietary intake during pregnancy.
Comprehensive history and physical examination findings related to magnesium levels.
Follow-up visits for infants with a history of hypomagnesemia.
Monitoring growth and development in infants with previous magnesium deficiencies.
Used to monitor magnesium levels in infants diagnosed with hypomagnesemia.
Document the reason for testing and any clinical symptoms present.
Neonatologists should ensure timely testing in high-risk infants.
Common causes include maternal magnesium deficiency, prematurity, and certain medications. It's essential to assess maternal health and dietary intake during pregnancy.
